US Stock IR Daily – April 16, 2026 (6 reports)

• U.S. Bancorp filed a Form 8-K report on April 16, 2026.
• This filing pertains to the company’s results of operations and financial condition for the quarter ended March 31, 2026.
• On April 16, 2026, U.S. Bancorp issued a press release reporting these financial results, which is attached as Exhibit 99.1 to the 8-K.
• Additionally, the company made available an “1Q26 Earnings Supplement” with further financial information on its website, attached as Exhibit 99.2 to the 8-K.

This 8-K filing officially communicates U.S. Bancorp’s release of its first-quarter 2026 financial results. Investors seeking detailed financial performance metrics will likely refer to the accompanying press release (Exhibit 99.1) and the earnings supplement (Exhibit 99.2) made available by the company. These documents are typically key sources for understanding the latest operational and financial health of the company.

• The Travelers Companies, Inc. (TRV) announced its results of operations for the quarter ended March 31, 2026, on April 16, 2026.
• The company issued a press release concerning its first quarter financial performance.
• A first quarter financial supplement was made available on the company’s website.
• These announcements were furnished as part of a Form 8-K filed with the U.S. Securities and Exchange Commission on April 16, 2026.

This 8-K filing primarily serves to inform the market that Travelers has released its first-quarter 2026 operational results. While the filing itself does not contain detailed financial figures, it indicates the availability of a comprehensive press release and a financial supplement on the company’s website. Investors interested in the specific performance metrics and analyses would typically refer to these additional documents for a full understanding of the quarter’s results.

• Abbott Laboratories announced its results of operations for the first quarter 2026 on April 16, 2026.
• These results were released via a news release furnished as Exhibit 99.1 to the 8-K filing.
• The company explained its use of non-GAAP financial measures, which exclude items such as expenses primarily associated with acquisitions, stock-based compensation, restructuring actions, certain regulatory costs, and intangible amortization expense.
• These non-GAAP measures are utilized by management to assess business performance and are intended to provide investors with useful information regarding ongoing business performance.
• Investors are cautioned to consider these non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP.

Abbott Laboratories has confirmed the announcement of its first-quarter 2026 operating results, providing an update on its recent business performance. This information may be useful for investors monitoring the company’s operational trajectory. The detailed explanation of the company’s non-GAAP financial measures could offer additional insights into how management evaluates core business performance, beyond standard accounting principles.

• Prologis, Inc. announced its financial results for the first quarter of 2026 on April 16, 2026.
• The announcement was made through a press release, a copy of which was furnished as Exhibit 99.2 to the Form 8-K filing.
• Supplemental information pertaining to the financial results was also furnished as Exhibit 99.1.
• This disclosure was made pursuant to Item 2.02, “Results of Operations and Financial Condition,” and Item 7.01, “Regulation FD Disclosure,” of Form 8-K.
• Prologis, Inc. serves as the general partner of Prologis, L.P.

The release of Prologis’s routine quarterly financial results provides a key moment for investors to assess the company’s recent operational performance and financial health. This announcement serves to maintain corporate transparency and offers foundational data for market participants to understand current business trends and potential future strategies within the industrial real estate sector. The market will likely turn its attention to the detailed financial figures and any accompanying management commentary in the exhibits.

• Netflix, Inc. announced its financial results for the quarter ended March 31, 2026, on April 16, 2026.
• On April 10, 2026, Reed Hastings informed the Company of his decision not to stand for re-election as a director at the 2026 annual meeting of stockholders.
• Mr. Hastings’ current term as a director and Chairman of the Board will expire at the upcoming Annual Meeting.
• He will continue to serve as a director and Chairman of the Board until the Annual Meeting.
• His decision not to seek re-election is not due to any disagreement with the Company.

This announcement includes two significant developments: the Q1 2026 financial results and Reed Hastings’ decision not to seek re-election as a director. The financial results, detailed in the Letter to Shareholders, will likely provide insights into the company’s operational performance for the period. Hastings’ stepping down from the board, while continuing as Chairman until the annual meeting and not due to disagreements, could mark a notable transition in the company’s governance structure, and investors may monitor future leadership developments.

• The Charles Schwab Corporation filed a Form 8-K with the Securities and Exchange Commission (SEC) on April 16, 2026.
• This filing serves as a current report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
• The company reported that it issued a press release on April 16, 2026, announcing its financial results for the quarter ended March 31, 2026.
• The aforementioned press release was furnished as Exhibit 99.1 to the Form 8-K.

This Form 8-K filing indicates that The Charles Schwab Corporation has officially released its financial results for the first quarter of 2026. While the specific financial figures are not detailed within this particular 8-K document, the filing serves to publicly disclose the issuance of a separate press release containing those results. Investors may consider this an important procedural announcement confirming the timely release of quarterly performance data.